Belgian Pharmaceuticals & Biotech Leverage Leaders

UCB

Market Cap: €52.3b

A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.

argenx

Market Cap: €42.4b

A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.

Financière de Tubize

Market Cap: €10.1b

Operates as a mono holding company whose sole investment is a stake in UCB which is a biopharma company in Belgium.